PODD - Insulet Corporation
IEX Last Trade
202.77
-2.380 -1.174%
Share volume: 606,015
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$205.15
-2.38
-1.16%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-06 | 2022-08-05 | 2022-11-04 | 2023-02-24 | 2023-05-05 | 2023-08-09 | 2023-11-03 | 2024-02-23 | |
| Assets | |||||||||
| Total Assets | 2.069 B | 2.114 B | 2.166 B | 2.251 B | 2.289 B | 2.386 B | 2.468 B | 2.588 B | |
| Current Assets | 1.285 B | 1.309 B | 1.329 B | 1.314 B | 1.330 B | 1.422 B | 1.471 B | 1.583 B | |
| Inventories | 314.800 M | 320.400 M | 327.600 M | 346.800 M | 386.100 M | 411.300 M | 410.800 M | 402.600 M | |
| Other Current Assets | 71.700 M | 73.500 M | 78.100 M | 86.900 M | 106.000 M | 99.600 M | 104.600 M | 116.400 M | |
| Short Term Investments | 71.700 M | 73.500 M | 78.100 M | 86.900 M | 106.000 M | 99.600 M | 104.600 M | 116.400 M | |
| Total Receivables | 189.300 M | 206.600 M | 201.400 M | 205.600 M | 217.200 M | 250.500 M | 270.300 M | 359.700 M | |
| Current Cash | 709.600 M | 708.600 M | 722.000 M | 674.700 M | 620.700 M | 660.100 M | 685.400 M | 704.200 M | |
| Total Non-current Assets | 783.800 M | 804.600 M | 837.100 M | 937.100 M | 959.100 M | 964.300 M | 996.600 M | 1.005 B | |
| Property Plant Equipment | 538.200 M | 535.800 M | 553.100 M | 599.900 M | 596.600 M | 601.500 M | 649.200 M | 664.900 M | |
| Other Assets | 141.000 M | 161.900 M | 178.700 M | 210.000 M | 210.600 M | 211.600 M | 196.200 M | 190.000 M | |
| Intangible Assets | 52.800 M | 55.100 M | 53.700 M | 75.500 M | 100.200 M | 99.500 M | 99.500 M | 98.700 M | |
| Goodwill | 51.800 M | 51.800 M | 51.600 M | 51.700 M | 51.700 M | 51.700 M | 51.700 M | 51.700 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.069 B | 2.114 B | 2.166 B | 2.251 B | 2.289 B | 2.386 B | 2.468 B | 2.588 B | |
| Total liabilities | 1.623 B | 1.691 B | 1.738 B | 1.775 B | 1.786 B | 1.832 B | 1.860 B | 1.856 B | |
| Total current liabilities | 215.000 M | 279.300 M | 334.200 M | 364.700 M | 383.300 M | 425.000 M | 451.400 M | 451.200 M | |
| Accounts Payable | 52.200 M | 57.200 M | 62.100 M | 30.800 M | 85.900 M | 107.500 M | 77.800 M | 19.200 M | |
| Other liabilities | 17.000 M | 26.800 M | 24.200 M | 35.700 M | 34.200 M | 38.300 M | 38.200 M | 37.900 M | |
| Current long term debt | 25.700 M | 26.300 M | 26.900 M | 27.500 M | 27.800 M | 29.200 M | 49.800 M | 49.400 M | |
| Long term debt | 1.391 B | 1.385 B | 1.380 B | 1.374 B | 1.369 B | 1.369 B | 1.371 B | 1.366 B | |
| Other liabilities | 17.000 M | 26.800 M | 24.200 M | 35.700 M | 34.200 M | 38.300 M | 38.200 M | 37.900 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 446.700 M | 422.400 M | 428.000 M | 476.400 M | 502.800 M | 553.900 M | 607.500 M | 732.700 M | |
| Common stock | 69.254 M | 69.356 M | 69.418 M | 69.472 M | 69.583 M | 69.741 M | 69.823 M | 69.857 M | |
| Retained earnings | -561.100 M | -596.100 M | -601.300 M | -584.300 M | -560.500 M | -533.200 M | -481.300 M | -378.000 M |